Art. 52 Regulation (EU) 2017/745

Conformity assessment procedures

In forcesince 19 Jul 2026cited 22×
1.

Prior to placing a device on the market, manufacturers shall undertake an assessment of the conformity of that device, in accordance with the applicable conformity assessment procedures set out in Annexes IX to XI.

2.

Prior to putting into service a device that is not placed on the market, manufacturers shall undertake an assessment of the conformity of that device, in accordance with the applicable conformity assessment procedures set out in Annexes IX to XI.

3.

Manufacturers of class III devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Annex X coupled with a conformity assessment as specified in Annex XI.

4.

Manufacturers of class IIb devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Chapters I and III of Annex IX, and including an assessment of the technical documentation as specified in Section 4 of that Annex of at least one representative device per generic device group.

However, for class IIb implantable devices, the assessment of the technical documentation as specified in Section 4 of Annex IX shall apply for every device, except for the following class IIb implantable devices:

(a)

sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips, connectors,

(b)

cannulas, catheters, feeding tubes, suture pledgets, suture sleeves, suture buttons, gastrostomy buttons, bone wax, bone fillers, bone substitutes, stem centralisers, diaphyseal obturators, radiography markers, fiber ligatures, transpalatal distractors, nails, anchors, spinal posterior fixations, textile braids, dental implants, orthodontic devices, dental barriers, suspensory fixations and cinches.

Alternatively, the manufacturer may choose to apply a conformity assessment based on type examination as specified in Annex X coupled with a conformity assessment based on product conformity verification as specified in Annex XI.

5.

Where justified in view of well-established technologies, similar to those used in the exempted devices listed in the second subparagraph of paragraph 4 of this Article, being used in other class IIb implantable devices, or where justified in order to protect the health and safety of patients, users or other persons or other aspects of public health, the Commission is empowered to adopt delegated acts in accordance with Article 115 to amend that list by adding other types of class IIb implantable devices to that list or removing devices therefrom.

6.

Manufacturers of class IIa devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Chapters I and III of Annex IX, and including an assessment of the technical documentation as specified in Section 4 of that Annex of at least one representative device for each category of devices.

Alternatively, the manufacturer may choose to draw up the technical documentation set out in Annexes II and III coupled with a conformity assessment as specified in Section 10 or Section 18 of Annex XI. The assessment of the technical documentation shall apply for at least one representative device for each category of devices.

7.

Manufacturers of class I devices, other than custom-made or investigational devices, shall declare the conformity of their products by issuing the EU declaration of conformity referred to in Article 19 after drawing up the technical documentation set out in Annexes II and III. If those devices are placed on the market in sterile condition, have a measuring function or are reusable surgical instruments, the manufacturer shall apply the procedures set out in Chapters I and III of Annex IX, or in Part A of Annex XI. However, the involvement of the notified body in those procedures shall be limited:

(a)

in the case of devices placed on the market in sterile condition, to the aspects relating to establishing, securing and maintaining sterile conditions;

(b)

in the case of devices with a measuring function, to the aspects relating to the conformity of the devices with the metrological requirements;

(c)

in the case of reusable surgical instruments, to the aspects relating to the reuse of the device, in particular cleaning, disinfection, sterilization, maintenance and functional testing and the related instructions for use.

8.

Manufacturers of custom-made devices shall follow the procedure set out in Annex XIII and draw up the statement set out in Section 1 of that Annex before placing such devices on the market.

In addition to the procedure applicable pursuant to the first subparagraph, manufacturers of class III custom-made implantable devices shall be subject to the conformity assessment as specified in Chapter I of Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Part A of Annex XI.

9.

In addition to the procedures applicable pursuant to paragraph 3, 4, 6, or 7 of this Article, in the case of devices referred to in the first subparagraph of Article 1(8), the procedure specified in Section 5.2 of Annex IX or Section 6 of Annex X, as applicable, shall also apply.

10.

In addition to the procedures applicable pursuant to paragraph 3, 4, 6, or 7 of this Article, in the case of devices that are covered by this Regulation in accordance with point (f) or (g) of Article 1(6) and with the first subparagraph of Article 1(10), the procedure specified in Section 5.3 of Annex IX or Section 6 of Annex X, as applicable, shall also apply.

11.

In addition to the procedures applicable pursuant to paragraph 3, 4, 6, or 7, in the case of devices that are composed of substances or of combinations of substances that are intended to be introduced into the human body via a body orifice or applied to the skin and that are absorbed by or locally dispersed in the human body, the procedure specified in Section 5.4 of Annex IX or Section 6 of Annex X, as applicable, shall also apply.

12.

The Member State in which the notified body is established may require that all or certain documents, including the technical documentation, audit, assessment and inspection reports, relating to the procedures referred to in paragraphs 1 to 7 and 9 to 11 be made available in an official Union language(s) determined by that Member State. In the absence of such requirement, those documents shall be available in any official Union language acceptable to the notified body.

13.

Investigational devices shall be subject to the requirements set out in Articles 62 to 81.

14.

The Commission may, by means of implementing acts, specify detailed arrangements and procedural aspects with a view to ensuring the harmonised application of the conformity assessment procedures by the notified bodies for any of the following aspects:

(a)

the frequency and the sampling basis of the assessment of the technical documentation on a representative basis as set out in the third paragraph of Section 2.3 and in Section 3.5 of Annex IX in the case of class IIa and class IIb devices, and in Section 10.2 of Annex XI in the case of class IIa devices;

(b)

the minimum frequency of unannounced on-site audits and sample tests to be conducted by notified bodies in accordance with Section 3.4 of Annex IX, taking into account the risk-class and the type of device;

(c)

the physical, laboratory or other tests to be carried out by notified bodies in the context of sample tests, assessment of the technical documentation and type examination in accordance with Sections 3.4 and 4.3 of Annex IX, Section 3 of Annex X and Section 15 of Annex XI.

The implementing acts referred to in the first subparagraph shall be adopted in accordance with the examination procedure referred to in Article 114(3).

The 10 that are cited most themselves, of 22.

  • Verordnung über das Betreiben und Benutzen von Medizinprodukten9Law

    … zur Durchführung eines Konformitätsbewertungsverfahrens nach Artikel 52 der Verordnung (EU) 2017/745, 2. zur Aushändigung der Informationen und Unterlagen für den Nachweis der Konformität des Produktes nach Artikel 10 Absatz 14 der …

  • MPDG79293Law

    … auf Antrag das Inverkehrbringen oder die Inbetriebnahme von Produkten, bei denen die Verfahren nach Maßgabe von Artikel 52 der Verordnung (EU) 2017/745 oder Artikel 48 der Verordnung (EU) 2017/746 nicht durchgeführt wurden, im …

  • The Medical Devices Regulations 200219bLaw

    … 11 required the involvement of a notified body; or (b) the conformity assessment procedure for that device under Article 52 of Regulation (EU) 2017/745 would require the involvement of a notified body (if it were to be assessed under that …

  • The Medical Devices (Amendment) (Great Britain) Regulations 20236Law

    … 11 required the involvement of a notified body; or (b) the conformity assessment procedure for that device under Article 52 of Regulation (EU) 2017/745 would require the involvement of a notified body (if it were to be assessed under that …

  • Opinion of Advocate General Spielmann delivered on 11 September 2025. Dürr Dental SE v Cattani Deutschland Helmes GmbH & Co. KG.Decision

    It should be recalled that, in essence, the manufacturer has to determine the class of its medical device in order to determine the applicable requirements. Under Article 51(1) of Regulation 2017/745, ‘devices shall be divided into …

    11 Sep 2025 · 62024CC0010

  • Code de la santé publiquel5211-3Law

    … par dérogation à l'obligation d'évaluation préalable de la conformité de chaque dispositif prévue à l'article 52 du règlement (UE) 2017/745, autoriser la mise sur le marché ou la mise en service sur le territoire français d'un …

  • Medizinproduktegesetz 2021783Law

    … gemäß Art. 52 Abs. 12 der Verordnung (EU) Nr. 745/2017 im Zusammenhang mit den in Abs. 1 bis 7 und 9 bis 11 dieses Art. genannten Verfahren, oder 2. gemäß Art. 48 Abs. 12 der Verordnung (EU) Nr. 746/2017 im Zusammenhang mit den in Abs. …

  • Gesetz zum Implantateregister Deutschland29Law

    … nach Artikel 10 der Verordnung (EU) 2017/745, b) zur Durchführung des Konformitätsbewertungsverfahrens nach Artikel 52 der Verordnung (EU) 2017/745, c) zur Überwachung ihrer Produkte nach dem Inverkehrbringen im Sinne des Artikels 83 …

  • BGH, EuGH-Vorlage vom 21. Dezember 2023 - I ZR 17/23Decision

    … den Feststellungen des Berufungsgerichts nicht die Kennnummer der für die Konformitätsbewertungsverfahren gemäß Art. 52 der Verordnung (EU) 2017/745 zuständigen Benannten Stelle hinzugefügt war.

    21 Dec 2023 · KORE305492023

  • Regulation (EU) 2022/23462Law

    … (UE) 2017/745 et aux spécifications communes énoncées dans le présent règlement, ainsi que pour lequel l’article 52 du règlement (UE) 2017/745 exige une évaluation de la conformité faisant intervenir un organisme notifié, peut …